Glucose meters views sought
Federal authorities are accepting comments through the first week of April on newly proposed stricter guidelines for blood glucose monitoring systems.
The more stringent FDA guidance focuses on infection-control measures. For the first time, it also differentiates regulation for glucose meters used in clinical settings from those used by individuals for self-monitoring. The FDA has been working on the issue since 2010.
A draft version was published in the Federal Register Jan. 7. It covers systems used in nursing homes and hospitals.